190 related articles for article (PubMed ID: 27472708)
21. Lack of correlation between the antibody to hepatitis B core antigen and survival after surgical resection for hepatitis C virus-related hepatocellular carcinoma.
Nishikawa H; Arimoto A; Wakasa T; Kita R; Kimura T; Osaki Y
Oncol Rep; 2013 Jul; 30(1):91-8. PubMed ID: 23615658
[TBL] [Abstract][Full Text] [Related]
22. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
[TBL] [Abstract][Full Text] [Related]
23. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
[TBL] [Abstract][Full Text] [Related]
24. Serological and Molecular Diagnosis of Occult Hepatitis B Virus Infection in Hepatitis C Chronic Liver Diseases.
Daef EA; Makhlouf NA; Ahmed EH; Mohamed AI; Abd El Aziz MH; El-Mokhtar MA
Egypt J Immunol; 2017 Jan; 24(1):37-48. PubMed ID: 29120576
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
[TBL] [Abstract][Full Text] [Related]
26. Detection of serum HBV DNA and anti-HCV antibody in HBsAg seronegative patients with hepatocellular carcinoma in Japan.
Tokeshi S; Sata M; Tanikawa K
Kansenshogaku Zasshi; 1996 Feb; 70(2):103-7. PubMed ID: 8851381
[TBL] [Abstract][Full Text] [Related]
27. Effects of Positive Hepatitis B Core Antibody and Metabolic Disorders in Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus.
Lee HL; Bae SH; Lee J; Sung PS; Lee SW; Jang JW; Lee J; Choi JY; Han NI; Yoon SK
Cancer Control; 2021; 28():10732748211039758. PubMed ID: 34569320
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
[TBL] [Abstract][Full Text] [Related]
29. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Chan TT; Chan WK; Wong GL; Chan AW; Nik Mustapha NR; Chan SL; Chong CC; Mahadeva S; Shu SS; Lai PB; Chan HL; Wong VW
Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781
[TBL] [Abstract][Full Text] [Related]
30. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California.
Yu MC; Yuan JM; Ross RK; Govindarajan S
Hepatology; 1997 Jan; 25(1):226-8. PubMed ID: 8985295
[TBL] [Abstract][Full Text] [Related]
31. Is anti-HBc IgM a useful clinical test in patients with HBsAg-positive chronic hepatitis or primary hepatocellular carcinoma?
Lai MC; Tong MJ; Nowicki MJ; Lee SD
Hepatology; 1988; 8(3):514-7. PubMed ID: 2453429
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma in Korea.
Park BC; Han BH; Ahn SY; Lee SW; Lee DH; Lee YN; Seo JH; Kim KW
J Viral Hepat; 1995; 2(4):195-202. PubMed ID: 7489347
[TBL] [Abstract][Full Text] [Related]
33. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53.
Shiota G; Oyama K; Udagawa A; Tanaka K; Nomi T; Kitamura A; Tsutsumi A; Noguchi N; Takano Y; Yashima K; Kishimoto Y; Suou T; Kawasaki H
J Med Virol; 2000 Oct; 62(2):151-8. PubMed ID: 11002243
[TBL] [Abstract][Full Text] [Related]
34. Analysis of risk factors for hepatocellular carcinoma that is negative for hepatitis B surface antigen (HBsAg).
Shimada S; Aizawa R; Abe H; Suto S; Miyakawa Y; Aizawa Y
Intern Med; 2003 May; 42(5):389-93. PubMed ID: 12793707
[TBL] [Abstract][Full Text] [Related]
35. Cellular localization of hepatitis B virus antigens in patients with hepatocellular carcinoma coexisting with liver cirrhosis.
Nazarewicz T; Krawczyński K; Slusarczyk J; Nowosławski A
J Infect Dis; 1977 Feb; 135(2):298-302. PubMed ID: 190331
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study.
Weinig M; Hakim JG; Gudza I; Tobaiwa O
Trans R Soc Trop Med Hyg; 1997; 91(5):570-2. PubMed ID: 9463670
[TBL] [Abstract][Full Text] [Related]
37. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
Tanaka H; Iwasaki Y; Nouso K; Kobayashi Y; Nakamura S; Matsumoto E; Toshikuni N; Kaneyoshi T; Ohsawa T; Takaguchi K; Fujio K; Senoh T; Ohnishi T; Sakaguchi K; Shiratori Y
J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan.
Marusawa H; Osaki Y; Kimura T; Ito K; Yamashita Y; Eguchi T; Kudo M; Yamamoto Y; Kojima H; Seno H; Moriyasu F; Chiba T
Gut; 1999 Aug; 45(2):284-8. PubMed ID: 10403743
[TBL] [Abstract][Full Text] [Related]
39. Liver histology in patients with HBsAg negative anti-HBc and anti-HCV positive chronic hepatitis.
Sagnelli E; Pasquale G; Coppola N; Marrocco C; Scarano F; Imparato M; Sagnelli C; Scolastico C; Piccinino F
J Med Virol; 2005 Feb; 75(2):222-6. PubMed ID: 15602732
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B virus, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma.
Trichopoulos D; Day NE; Kaklamani E; Tzonou A; Muñoz N; Zavitsanos X; Koumantaki Y; Trichopoulou A
Int J Cancer; 1987 Jan; 39(1):45-9. PubMed ID: 3025110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
